Scientists are creating extraordinarily detailed maps of the human brain to understand why Alzheimer’s disease develops differently from person to person.
An NIH-supported research effort conducted one of the largest comparative investigations of human brain disorders at single-cell resolution. Instead of treating brain tissue as one uniform sample, researchers examined the molecular activity of individual types of brain cells.
A related analysis examined more than 6.3 million cells from 1,494 human donors, with samples spanning an exceptionally wide age range—from infancy to 108 years old.
Researchers studied gene activity in the prefrontal cortex, a region involved in complex functions such as decision-making, working memory and behaviour. By comparing enormous numbers of cells, scientists could identify molecular patterns associated with normal ageing as well as neurological and psychiatric disorders.
The research also explored one of Alzheimer’s most intriguing mysteries: some people accumulate biological signs associated with the disease yet maintain relatively strong cognitive abilities. Understanding what makes these individuals resilient could potentially reveal natural protective mechanisms.
These detailed cellular maps are somewhat similar to creating a highly sophisticated atlas. Instead of simply showing where different brain regions are located, they reveal which genes are active, which cells are changing and which molecular pathways may be disrupted.
Such datasets could eventually help researchers identify more precise drug targets and classify patients according to the biological mechanisms driving their disease.
The research does not immediately produce a new Alzheimer’s treatment. Its importance lies in giving scientists a much more detailed foundation from which future treatments can be developed.
